2020 Q4 Form 10-Q Financial Statement

#000121390020037298 Filed on November 16, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2020 Q2
Revenue $4.110M $3.714M $3.004M
YoY Change 24.17% 16.32% -17.03%
Cost Of Revenue $1.400M $1.740M $1.819M
YoY Change -13.33% 26.11% 68.39%
Gross Profit $2.710M $1.974M $1.185M
YoY Change 60.26% 8.87% -53.34%
Gross Profit Margin 65.94% 53.15% 39.45%
Selling, General & Admin $3.800M $4.568M $5.243M
YoY Change -22.18% 26.82% -60.1%
% of Gross Profit 140.22% 231.38% 442.43%
Research & Development $1.410M $1.759M $1.089M
YoY Change 126.14% 187.91% -59.52%
% of Gross Profit 52.03% 89.1% 91.89%
Depreciation & Amortization $840.0K $1.171M $1.320M
YoY Change 6442.39%
% of Gross Profit 31.0% 59.32% 111.39%
Operating Expenses $6.040M $7.498M $7.368M
YoY Change 9.69% 77.98% -12.18%
Operating Profit -$3.330M -$5.523M -$6.183M
YoY Change -12.73% 130.2% 5.7%
Interest Expense -$1.930M -$3.687K -$2.084K
YoY Change -3960.0% -105.27% -110.42%
% of Operating Profit
Other Income/Expense, Net -$60.00K $1.537M $157.0K
YoY Change 2002.69%
Pretax Income -$12.20M -$3.987M -$6.026M
YoY Change 181.11% 71.36% 3.55%
Income Tax $0.00 $30.99K
% Of Pretax Income
Net Earnings -$12.22M -$3.979M -$5.313M
YoY Change 224.68% 71.05% -8.72%
Net Earnings / Revenue -297.32% -107.14% -176.87%
Basic Earnings Per Share
Diluted Earnings Per Share -$811.4K -$337.1K -$221.6K
COMMON SHARES
Basic Shares Outstanding 19.69M shares 14.69M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.84M $14.26M $24.16M
YoY Change -5.01% -36.42% 10.47%
Cash & Equivalents $17.84M $14.26M $24.16M
Short-Term Investments
Other Short-Term Assets $2.960M $1.980M $1.710M
YoY Change 83.85% 44.53% 58.33%
Inventory
Prepaid Expenses $2.459M $1.215M
Receivables $1.754M $2.799M $1.862M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $22.55M $19.03M $27.73M
YoY Change 1.87% -27.66% 14.59%
LONG-TERM ASSETS
Property, Plant & Equipment $1.193M $1.396M $131.1K
YoY Change
Goodwill $41.87M $46.50M $20.25M
YoY Change 106.74%
Intangibles $7.389M
YoY Change
Long-Term Investments $233.7K $240.0K $250.0K
YoY Change -6.53%
Other Assets $41.93K $41.93K
YoY Change
Total Long-Term Assets $54.62M $62.30M $30.80M
YoY Change 21746.46%
TOTAL ASSETS
Total Short-Term Assets $22.55M $19.03M $27.73M
Total Long-Term Assets $54.62M $62.30M $30.80M
Total Assets $77.17M $81.33M $58.53M
YoY Change 244.66% 209.14% 141.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $513.6K $6.000M $1.444M
YoY Change -69.24% 275.0% 9.59%
Accrued Expenses $3.420M
YoY Change 584.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $2.000M $0.00
YoY Change
Long-Term Debt Due $11.71M $10.15M $6.140M
YoY Change
Total Short-Term Liabilities $16.05M $18.13M $11.75M
YoY Change 421.14% 504.39% 381.27%
LONG-TERM LIABILITIES
Long-Term Debt $3.895M $5.480M $10.20M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.895M $5.480M $10.20M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $16.05M $18.13M $11.75M
Total Long-Term Liabilities $3.895M $5.480M $10.20M
Total Liabilities $19.95M $23.61M $23.01M
YoY Change 547.61% 687.11% 319.61%
SHAREHOLDERS EQUITY
Retained Earnings -$57.18M $0.20 -$41.15M
YoY Change 49.21%
Common Stock $94.09M $83.17M $71.90M
YoY Change 55.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $57.22M $57.72M $35.52M
YoY Change
Total Liabilities & Shareholders Equity $77.17M $81.33M $58.53M
YoY Change 244.66% 209.14% 141.84%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$12.22M -$3.979M -$5.313M
YoY Change 224.68% 71.05% -8.72%
Depreciation, Depletion And Amortization $840.0K $1.171M $1.320M
YoY Change 6442.39%
Cash From Operating Activities -$4.530M -$4.181M -$2.750M
YoY Change 14.97% 33.07% 2.23%
INVESTING ACTIVITIES
Capital Expenditures -$1.220M -$640.0K -$3.260M
YoY Change 23.08%
Acquisitions
YoY Change
Other Investing Activities -$210.0K -$5.070M -$140.0K
YoY Change -16.0% -100.74%
Cash From Investing Activities -$1.440M -$5.705M -$3.400M
YoY Change -633.33% 997.63% -118.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.540M -$12.67K 15.98M
YoY Change 95300.0% -100.3%
NET CHANGE
Cash From Operating Activities -4.530M -$4.181M -2.750M
Cash From Investing Activities -1.440M -$5.705M -3.400M
Cash From Financing Activities 9.540M -$12.67K 15.98M
Net Change In Cash 3.570M -$9.898M 9.830M
YoY Change -197.54% -1804.96% -39.13%
FREE CASH FLOW
Cash From Operating Activities -$4.530M -$4.181M -$2.750M
Capital Expenditures -$1.220M -$640.0K -$3.260M
Free Cash Flow -$3.310M -$3.541M $510.0K
YoY Change 35.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
131095 USD
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2667349 shares
CY2020Q3 us-gaap Liabilities
Liabilities
23613226 USD
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5998001 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41925 USD
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4861928 USD
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
31870154 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1395690 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1475613 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
1321 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11754977 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
57721556 USD
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2020Q3 kern Capitalized Software Net
CapitalizedSoftwareNet
3389646 USD
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81334782 USD
CY2020Q2 us-gaap Minority Interest
MinorityInterest
4704252 USD
CY2020Q3 kern Current Contingent Consideration
CurrentContingentConsideration
817000 USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1215341 USD
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14685932 shares
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58529619 USD
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2020Q2 kern Net Investment Non Current
NetInvestmentNonCurrent
246308 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 kern Revenue Frome Consulting
RevenueFromeConsulting
331080 USD
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13258707 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13258707 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14685932 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
610902 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2097502 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1534 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-287 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
1974067 USD
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10879112 shares
CY2019Q3 us-gaap Revenues
Revenues
3192890 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
73095 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-2326332 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
4212616 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
1739937 USD
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
73382 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
7497537 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2399427 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-4741876 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2326332 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2326332 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
1813189 USD
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
17899 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4749157 USD
CY2020Q3 kern Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
778000 USD
CY2020Q3 us-gaap Revenues
Revenues
3714004 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-4750691 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
774313 USD
CY2019Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4242454 USD
CY2020Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
12668 USD
CY2019Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
252809 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22367289 USD
CY2019Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-519739 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4181159 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14757858 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22947830 USD
CY2020Q3 kern Current Contingent Liability
CurrentContingentLiability
817000 USD
CY2019Q3 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Percentage
BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
0.01 pure
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3881386 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
983731 USD
CY2020Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
10200236 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
36574406 USD
CY2020Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020Q3 dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19685932 shares
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57721556 USD
CY2020Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
368685 USD
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
500000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
20254309 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
63000 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
1464 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
18131627 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1861534 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
27732703 USD
CY2020Q3 us-gaap Goodwill
Goodwill
46500030 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45842967 USD
CY2020Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1170625 USD
CY2020Q2 kern Current Contingent Consideration
CurrentContingentConsideration
389000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2799225 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
500000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1841514 USD
CY2020Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q3 dei Document Type
DocumentType
10-Q
CY2020Q3 dei Amendment Flag
AmendmentFlag
false
CY2020Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001755953
CY2020Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q3 dei Entity File Number
EntityFileNumber
001-39096
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
4999999 shares
CY2020Q3 us-gaap Assets
Assets
81334782 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24155828 USD
CY2020Q3 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
83164840 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7000 USD
CY2019Q3 kern Amortization Of Stock Based Compensation
AmortizationOfStockBasedCompensation
161165 USD
CY2020Q3 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
10146001 USD
CY2020Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
10730021 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
72906924 USD
CY2020Q2 kern Capitalized Software Net
CapitalizedSoftwareNet
2629304 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9897970 USD
CY2020Q3 us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
12203 USD
CY2020Q1 kern Gross Profits
GrossProfits
1674327 USD
kern Gross Profits
GrossProfits
3504153 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.56
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
874787 USD
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4883172 USD
kern Net Losses
NetLosses
-10834156 USD
CY2019Q4 kern Gross Profits
GrossProfits
1690964 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8484886 USD
CY2019Q4 kern Cost Of Revenues
CostOfRevenues
1615239 USD
kern Gross Profits
GrossProfits
5178480 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.96
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2019Q3 kern Cost Of Revenues
CostOfRevenues
1379701 USD
CY2020Q1 kern Net Losses
NetLosses
-4744129 USD
CY2020Q1 kern Cost Of Revenues
CostOfRevenues
1396219 USD
kern Cost Of Revenues
CostOfRevenues
2994940 USD
kern Net Losses
NetLosses
-6090027 USD
CY2019Q4 kern Net Losses
NetLosses
-3763695 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2326332 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1234403 USD
CY2019Q3 kern Net Losses
NetLosses
-2326332 USD
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
623501 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14163128 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4820691 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-8815 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-70000 USD
CY2020Q2 kern Debt Purchase Price
DebtPurchasePrice
15000000 USD
CY2020Q2 us-gaap Convertible Debt
ConvertibleDebt
17000000 USD
CY2020Q1 kern Current Contingent Consideration
CurrentContingentConsideration
389000 USD
CY2020 kern Fair Value Assumption Expected Terms
FairValueAssumptionExpectedTerms
P2Y10M24D
CY2020Q3 kern Fair Value Assumption Expected Terms
FairValueAssumptionExpectedTerms
P2Y8M1D
CY2020Q3 kern Fair Value Assumptions Market Yield Rate
FairValueAssumptionsMarketYieldRate
0.280 pure
CY2020Q3 kern Fair Value Assumptions Volatility Rate
FairValueAssumptionsVolatilityRate
0.68 pure
CY2020Q3 kern Fair Value Assumptions Value Of Common Stock
FairValueAssumptionsValueOfCommonStock
3.64
CY2020Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
11.50
CY2020Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
17000000 USD
CY2020Q3 kern Change In Fair Value Reported In Other Comprehensive Income
ChangeInFairValueReportedInOtherComprehensiveIncome
70000 USD
CY2020Q2 kern Fair Value Assumption Risk Free Interest Rate
FairValueAssumptionRiskFreeInterestRate
0.002 pure
CY2020Q2 kern Fair Value Assumptions Market Yield Rate
FairValueAssumptionsMarketYieldRate
0.239 pure
CY2020Q2 kern Fair Value Assumptions Volatility Rate
FairValueAssumptionsVolatilityRate
0.45 pure
CY2020Q2 kern Fair Value Assumptions Value Of Common Stock
FairValueAssumptionsValueOfCommonStock
8.80
CY2020Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
11.50
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17899 USD
CY2020Q3 kern Acquisition Of Noncontrolling Interest
AcquisitionOfNoncontrollingInterest
USD
CY2020Q3 kern Amortization Of Stock Based Compensation
AmortizationOfStockBasedCompensation
764351 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23837021 USD
CY2019Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4242454 USD
CY2020Q3 us-gaap Asset At Fair Value Changes In Fair Value Resulting From Changes In Assumptions
AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions
-70000 USD
CY2020Q3 kern Restricted Stock Unit Vesting
RestrictedStockUnitVesting
USD
CY2020Q3 kern Exchangeable Shares Issued In Acquisition
ExchangeableSharesIssuedInAcquisition
25203490 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14257858 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2470187 USD
CY2019Q3 kern Revenues From Software
RevenuesFromSoftware
2254480 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2019Q3 kern Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
USD
CY2019Q3 kern Revenue Frome Consulting
RevenueFromeConsulting
831363 USD
CY2019Q3 kern Revenue From Other
RevenueFromOther
107047 USD
CY2020Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1171022 USD
CY2019Q3 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
519739 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-8815 USD
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14058412 shares
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1171022 USD
CY2020Q3 kern Revenue From Other
RevenueFromOther
228482 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3687 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1742301 USD
CY2020Q3 us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="margin: 0pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Note 1 - Description of Business, Liquidity and Capital <font><font><font>Resources</font></font></font></font></p> <p style="margin: 0pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</font></p> <p style="margin: 0pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Description of Business</font></p> <p style="margin: 0pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</font></p> <p style="margin: 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">Akerna Corp., herein referred to as we, our or Akerna, through our wholly owned subsidiaries MJ Freeway, LLC, or MJF, Trellis Solutions, Inc., or Trellis, Ample Organics, Inc, or Ample, and solo sciences, inc, or Solo, provides enterprise software solutions that enable regulatory compliance and inventory management. Our proprietary, broad and growing suite of solutions are adaptable for industries in which interfacing with government regulatory agencies for compliance purposes is required, or where the tracking of organic materials from seed or plant to end products is desired. We develop products intended to assist states in monitoring licensed businesses&#8217; compliance with state regulations and to help state-licensed businesses operate in compliance with such laws. We provide our commercial software platforms, MJ Platform<sup>&#174;</sup>, Ample and Trellis<sup>&#174;</sup>&nbsp;to state- or federally-licensed businesses, and our regulatory software platform, Leaf Data Systems<sup>&#174;</sup>, to state government regulatory agencies. Through Solo,</font><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">&nbsp;</font><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">we provide an innovative, next-generation solution for state and national governments to securely track product and waste throughout the supply chain with solo*TAG</font><font style="font-family: 'Times New Roman'; font-size: 6.67pt; vertical-align: super; line-height: inherit;">&#8482;</font><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">. The integration of MJ Platform<sup>&#174;</sup> and solo*CODE</font><font style="font-family: 'Times New Roman'; font-size: 6.67pt; vertical-align: super; line-height: inherit;">&#8482; </font><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">results in technology for consumers and brands that brings a consumer-facing mark designed to highlight authenticity and signify transparency.&nbsp;</font></p> <p style="margin: 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">&nbsp;</font></p> <p style="margin: 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">We consult with clients on a wide range of areas to help them successfully maintain compliance with state laws and regulations. We provide project-focused consulting services to clients who are initiating our expanding their cannabis business operations or are interested in data consulting engagements with respect to the legal cannabis industry. Our consulting engagements include service offerings focused on compliance requirement assessments, readiness and best practices, compliance monitoring systems, application processes, inspection readiness and business plan and compliance reviews. We typically provide our consulting services to clients in emerging markets who are seeking consultation on newly introduced licensing regimes and assistance with the regulatory compliant build-out of operations.&nbsp;</font></p> <p style="margin: 0pt; text-align: justify; text-indent: 36pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">&nbsp;</font></p> <p style="margin: 0pt; text-align: justify; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;">Fiscal Year-End</font><br/></p> <p style="margin: 0pt; text-align: justify; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; line-height: inherit;"><br/></font></p> <p style="margin: 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;"><font style="font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">On September 25, 2020, our Board of Directors adopted resolutions to change our fiscal year-end from June 30 to December 31, effective for the year ending December 31, 2020. We will cover the transition period from July 1, 2020 to December 31, 2020 by filing an Annual Report on Form 10-K for the transition year ending December 31, 2020.&nbsp;</font></font></p> <p style="margin: 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><font style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><br/></font></font></p> <p style="margin: 0pt; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;">Liquidity and <font style="line-height: inherit;">Capital <font style="line-height: inherit;">Resources</font></font></font></p> <p style="margin: 0pt; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;"><font style="line-height: inherit;"><font style="line-height: inherit;"><br/></font></font></font></p> <p style="margin: 0in; text-align: justify; line-height: 1.4;"><font style="line-height: inherit;"><font style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">Since our i<font style="line-height: inherit;">nception</font>, we have incurred recurring operating losses, used cash in operations, and relied on capital raising transactions to continue ongoing operations. During the three months ended September 30, 2020, we incurred a loss from operations of $<font>5.5</font> million and used cash in operations of $<font>4.2</font> million.<font style="line-height: inherit;">&nbsp; </font>As of September 30, 2020, we had cash of $<font>14.3</font> million, excluding restricted cash, and working capital of $<font>0.9</font> million.</font></font></p> <p style="margin: 0in; text-align: justify; line-height: 1.4;"><font style="line-height: inherit;">&nbsp;</font></p> <p style="margin: 0in; text-align: justify; line-height: 1.4;"><font style="line-height: inherit;"><font style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">During the quarter ended September 30, 2020, the Company incurred a number of <font>one</font>-time, non-recurring expenses of approximately $<font>1.1</font> million. These expenses include business combination expenses, restructuring and other non-recurring charges.<font style="line-height: inherit;">&nbsp; </font>Additionally, on October 30, 2020, we closed on the public offering of <font>5</font> million shares of common stock with proceeds of approximately $<font>11.0</font> million net of offering costs, which will be used for general corporate purposes. During the three months ended September 30, 2020 we implemented a number of <font>cost reduction initiatives reducing costs and identifying costs savings that we expect to result in annual savings of an additional $<font>3.0</font> million to $<font>4.0</font> million.<font style="line-height: inherit;">&nbsp;</font></font><font style="line-height: inherit;"> </font>As a result, we expect that our current working capital is sufficient to fund our operations and commitments for a period of at least <font>twelve</font> months from the date these financial statements are issued.</font></font></p> <p style="margin: 0in; text-align: justify; line-height: 1.4;"><font style="line-height: inherit;">&nbsp;</font></p> <p style="margin: 0in; text-align: justify; line-height: 1.4;"><font style="line-height: inherit;"><font style="font-family: 'times new roman', times; font-size: 10pt; line-height: inherit;">In the event the Company requires additional liquidity, the Company can further reduce or defer expenses. More specifically, the Company could implement certain discretionary cost reduction initiatives relating to our spend on employee travel and entertainment, consulting costs and marketing expenses, negotiate deferred salary arrangements, furlough employees or reduce headcount or negotiate extensions of payments of rent and utilities.<font style="line-height: inherit;">&nbsp; </font>The Company also believes it has access to capital through future debt or equity offerings and could be successful in renegotiating the maturity dates or conversion option relating to its current outstanding notes payable, although no assurance can be provided that we would be successful in these efforts.<font style="line-height: inherit;">&nbsp; </font>Further, the potential continues to exist that our $<font>2</font> million PPP loan could be forgiven. Management will continue to evaluate our liquidity and capital resources.&nbsp;</font></font></p> </div>
CY2020Q3 kern Conversion Of Exchangeable Share To Common Stock
ConversionOfExchangeableShareToCommonStock
4798271 USD
CY2020Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
12450 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5704806 USD
CY2020Q3 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
624863 USD
CY2020Q3 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2020Q3 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
245329 USD
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12668 USD
CY2019Q3 kern Capitalized Software Included In Accrued Expense
CapitalizedSoftwareIncludedInAccruedExpense
USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1758826 USD
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
1379701 USD
CY2020Q3 kern Revenues From Software
RevenuesFromSoftware
3154442 USD
CY2020Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
74023 USD
CY2019Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
USD
CY2020Q3 kern Change In Fair Value Of Convertible Debt
ChangeInFairValueOfConvertibleDebt
-778000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
25200000 USD
CY2020Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
7493975 USD
CY2020Q3 us-gaap Other Long Term Debt
OtherLongTermDebt
5481599 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2326332 USD
CY2019Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1508217 USD
CY2020Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9298 USD
CY2020Q3 kern Capitalized Software Included In Accrued Expense
CapitalizedSoftwareIncludedInAccruedExpense
807218 USD
CY2020Q3 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
4901 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
464575 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
426495 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
421418 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
439633 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
918847 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
226687 USD
CY2019Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
36000 USD
CY2020Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
273000 USD
CY2020Q3 kern Preferred Stock Liquidation Description
PreferredStockLiquidationDescription
special voting preferred stock has a par value of $0.0001 per share and a preference in liquidation of $1.00.
CY2020Q2 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
265000 USD
CY2019Q3 kern Conversion Of Exchangeable Share To Common Stock
ConversionOfExchangeableShareToCommonStock
USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5523470 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5678242 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2109190 USD
CY2019Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
4130000 USD
CY2020Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-4686000 USD
CY2020Q3 kern Revenue From Business Combinations
RevenueFromBusinessCombinations
1.2 USD
CY2020Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
149000 USD
CY2020Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
549000 USD
CY2020Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
30433000 USD
CY2020Q3 us-gaap Acquisition Costs
AcquisitionCosts
1000000 USD
CY2020Q3 us-gaap Cash
Cash
5724000 USD
CY2020Q3 kern Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Furniture Fixtures And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFurnitureFixturesAndEquipment
1327000 USD
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2667349 shares
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Description
BusinessCombinationContingentConsiderationArrangementsDescription
We acquired 100% of the stock of Ample Organics by issuing 3.3 million exchangeable shares of one of our wholly-owned subsidiaries. The exchangeable shares may be exchanged, at the option of the holder, for shares of Akerna common stock on a one-for-one basis, therefore the exchangeable shares issued were valued at $7.65 per share, the closing price of an equivalent share of Akerna common stock, for an aggregate value of $25.2 million. The exchangeable shares are economically equivalent to shares of Akerna common stock. In addition to the stock consideration, we paid $5.7 million in cash, which was used to settle all of Ample's then outstanding debt and transaction costs. The agreement provides for contingent consideration of up to CAD$10,000,000, payable in exchangeable shares, payable if Ample's Recurring Revenue recognized during the 12 months after the acquisition date is CAD$9,000,000 or more. The contingent consideration amount is reduced by an amount equal to the product of CAD$6.67 multiplied by the difference between CAD$9,000,000 and the amount of Recurring Revenue realized during the 12 months following the acquisition. The contingent consideration was recorded as the estimated fair value of $0.8 million as of the acquisition date and will be adjusted to the estimated fair value in each subsequent reporting period until settlement.
CY2020Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q3 dei Entity Registrant Name
EntityRegistrantName
Akerna Corp.
CY2020Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q2 us-gaap Assets
Assets
58529619 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41101091 USD
CY2020Q2 us-gaap Liabilities
Liabilities
21955213 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
19032696 USD
CY2020Q2 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
6135364 USD
CY2020Q3 kern Conversion Of Exchangeable Shares To Common Stock
ConversionOfExchangeableSharesToCommonStock
USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
21759734 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
580541 USD
CY2020Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
17000000 USD
CY2020Q2 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
14131000 USD
CY2020Q3 kern Changes In Fair Value Reported In Statements Of Operations
ChangesInFairValueReportedInStatementsOfOperations
-778000 USD
CY2020Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
445000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValue
0.0001
CY2020Q3 kern Net Income Loss From Bussiness Combinations
NetIncomeLossFromBussinessCombinations
0.4 USD
CY2020Q3 kern Preliminary Fair Value Of Consideration Transferred
PreliminaryFairValueOfConsiderationTransferred
31744000 USD
CY2020Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
31744000 USD
CY2020Q3 kern Exchangeable Shares Value
ExchangeableSharesValue
4798271 USD
CY2020Q3 kern Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accounts Payable And Accrued Expenses
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses
978000 USD
CY2019Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-4185000 USD
CY2020Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6029268 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10912224 shares
CY2020Q3 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
392000 USD
CY2019Q3 kern Gross Profits
GrossProfits
1813189 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3601714 USD
kern Cost Of Revenues
CostOfRevenues
4391159 USD
CY2020Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
917000 USD
CY2019Q3 us-gaap Payments To Acquire Furniture And Fixtures
PaymentsToAcquireFurnitureAndFixtures
USD
CY2019Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4242454 USD
CY2020Q3 kern Cash Acquired In Business Combination
CashAcquiredInBusinessCombination
5067740 USD
CY2020Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin: 0pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Concentrations of Credit Risk</font></p> <p style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 8pt 0pt 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">We grant credit in the normal course of business to customers in the United States. We periodically perform credit analysis and monitor the financial condition of our customers to reduce credit risk.</font><font class="ng-scope" style="font-family: 'Times New Roman'; font-size: 10pt;"></font></p> <p style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 8pt 0pt 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font class="ng-scope" style="font-family: 'Times New Roman'; font-size: 10pt;"><font class="ng-scope" style="/* background-color: #ffffff;">During the three months ended<font style="line-height: inherit;">&nbsp;</font><font>September 30, 2020,</font>&nbsp;and<font style="line-height: inherit;">&nbsp;</font><font class="ng-scope"><font>2019</font></font>,&nbsp;</font><font class="ng-scope"><font style="border-left: none; border-right: none; line-height: inherit;" class="ng-scope"><font>one</font></font></font><font style="/* background-color: #ffffff;">&nbsp;government client accounted for&nbsp;</font><font class="ng-scope"><font>17</font></font><font style="background-color: #ffff00;"><font class="ng-scope" style="background-color: #ffffff;">% and&nbsp;<font class="ng-scope"><font>24</font></font>% of total revenues, respectively.<font style="color: #000000; font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">&nbsp;</font>As of September<font> 30, 2020</font>,&nbsp;</font></font><font class="ng-scope"><font style="border-left: none; border-right: none; line-height: inherit;" class="ng-scope"><font>two</font></font></font><font class="ng-scope" style="/* background-color: #ffffff;">&nbsp;government clients accounted f<font>or a total of&nbsp;<font class="ng-scope" style="line-height: inherit;"><font>38</font>% and <font>20</font></font></font><font><font class="ng-scope" style="line-height: inherit;">%</font>&nbsp;</font>of net accounts receivable and <font>one</font> government client had outstanding receivables as of September 30, 2019, which accounted for <font>63</font>% of net accounts receivable.&nbsp;&nbsp;</font></font></p> </div>
CY2020Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
CY2020Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
2000000 USD
CY2020Q3 kern Non Recurring Expenses
NonRecurringExpenses
1100000 USD
CY2020Q3 kern Working Capital
WorkingCapital
900000 USD
CY2020Q2 us-gaap Noncurrent Assets
NoncurrentAssets
10254374 USD
CY2020Q3 kern Percentage Of Acquired Entity Ownership Acquired
PercentageOfAcquiredEntityOwnershipAcquired
1.00 pure
CY2020Q3 us-gaap Noncurrent Assets
NoncurrentAssets
15515357 USD
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2200000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
200000 USD
CY2020Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
451925 shares
CY2020Q3 kern Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
389000 USD
CY2019Q3 kern Change In Fair Value Of Convertible Debt
ChangeInFairValueOfConvertibleDebt
USD
CY2019Q3 kern Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
USD
CY2019Q3 kern Special Voting Preferred Stock Issued In Business Combination
SpecialVotingPreferredStockIssuedInBusinessCombination
USD
CY2020Q3 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin: 0pt; text-align: justify;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates</font></p> <p style="margin: 8pt 0pt 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">The preparation of our condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts included in the financial statements and accompanying notes thereto. Actual results could differ materially from those estimates.&nbsp;&nbsp;</font></p> </div>
CY2020Q3 kern Shareholders Exchanged
ShareholdersExchanged
627225 shares
CY2020Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
3790000 USD
CY2020Q1 us-gaap Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
291000 USD
CY2020Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin: 0pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Reclassifications and Revisions</font></p> <p style="margin: 0pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;">&nbsp;</font></p> <p style="margin: 0pt; text-align: justify; text-indent: 0pt; line-height: 1.4;"><font style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;" class="ng-scope">Certain prior year financial statement amounts have been reclassified for consistency with the current year presentation. Additionally, certain prior year financial statement amounts have been revised to correct misstatements in the prior year, please refer to Note <font>9</font> for additional information regarding the corrections.</font></p> </div>
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
200000 USD
CY2020Q3 kern Cost Reduction Initiatives Description
CostReductionInitiativesDescription
cost reduction initiatives reducing costs and identifying costs savings that we expect to result in annual savings of an additional $3.0 million to $4.0 million.
CY2020Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
681419 USD
CY2019Q3 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
278208 USD
CY2020Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
663 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41925 USD
CY2020Q3 kern Net Investment Non Current
NetInvestmentNonCurrent
244774 USD
CY2019Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
292272 USD
CY2019Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
161165 USD
CY2019Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3142174 USD
CY2019Q3 us-gaap Interest Paid Net
InterestPaidNet
1974 USD
CY2020Q3 us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
1534 USD
CY2020Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-296802 USD
CY2019Q3 kern Cash Acquired In Business Combination
CashAcquiredInBusinessCombination
USD
CY2019Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
USD
CY2020Q3 kern Special Voting Preferred Stock Issued In Business Combination
SpecialVotingPreferredStockIssuedInBusinessCombination
25203490 USD
CY2019Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
274566 USD
CY2020Q3 kern Acquisition Of Noncontrolling Interests
AcquisitionOfNoncontrollingInterests
4695437 USD
CY2019Q3 kern Acquisition Of Noncontrolling Interests
AcquisitionOfNoncontrollingInterests
USD
CY2019Q3 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24655828 USD

Files In Submission

Name View Source Status
0001213900-20-037298-index-headers.html Edgar Link pending
0001213900-20-037298-index.html Edgar Link pending
0001213900-20-037298.txt Edgar Link pending
0001213900-20-037298-xbrl.zip Edgar Link pending
ex311_1.htm Edgar Link pending
ex312_2.htm Edgar Link pending
ex321_3.htm Edgar Link pending
ex322_4.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img0un0rfvrm1201444772.jpg Edgar Link pending
img4pppfxy1dzv01444772.jpg Edgar Link pending
imgmv41vj0fei101445037.jpg Edgar Link pending
imgrptobozawyz01445042.jpg Edgar Link pending
imgs20azwuxqxl01445030.jpg Edgar Link pending
imgwcgffrcdqem01445051.jpg Edgar Link pending
kern-20200930.xml Edgar Link completed
kern-20200930.xsd Edgar Link pending
kern-20200930_cal.xml Edgar Link unprocessable
kern-20200930_def.xml Edgar Link unprocessable
kern-20200930_lab.xml Edgar Link unprocessable
kern-20200930_pre.xml Edgar Link unprocessable
MainDocument.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending